Eyenovia, Inc. (EYEN) financial statements (2022 and earlier)

Company profile

Business Address 295 MADISON AVENUE,
NEW YORK, NY 10017
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments19,46228,37214,15319,7285,250
Cash and cash equivalents19,46228,37214,15319,7285,250
Prepaid expense17111034390
Deferred costs 1,600  329
Other undisclosed current assets2,3693,30916393(292)
Total current assets:22,00233,39114,34919,8615,287
Noncurrent Assets
Property, plant and equipment1,2713962313728
Restricted cash and investments7,875    
Other undisclosed noncurrent assets511119118118329
Total noncurrent assets:9,657515348155357
TOTAL ASSETS:31,65933,90714,69820,0155,643
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,2952,6172,5562,546299
Accounts payable1,6141,4621,5411,510246
Accrued liabilities4229712453
Employee-related liabilities1,5441,151917912 
Interest and dividends payable953   
Deferred revenue 14,000 
Debt7,150195   
Deferred rent credit198  
Other undisclosed current liabilities7091,378356553253
Total current liabilities:11,17218,1982,9123,099553
Noncurrent Liabilities
Long-term debt and lease obligation 366   
Long-term debt, excluding current maturities 366   
Liabilities, other than long-term debt20394542 
Deferred rent credit20394542
Total noncurrent liabilities:204044542 
Total liabilities:11,19218,6032,9573,140553
Stockholders' equity
Stockholders' equity attributable to parent, including:20,46715,30411,74116,8755,091
Common stock32210
Additional paid in capital110,68392,74269,41053,38824,351
Accumulated deficit(90,219)(77,441)(57,671)(36,514)(19,261)
Other undisclosed stockholders' equity attributable to parent    0
Total stockholders' equity:20,46715,30411,74116,8755,091
TOTAL LIABILITIES AND EQUITY:31,65933,90714,69820,0155,643

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues14,0002,000   
Cost of revenue(1,600)(800)   
Gross profit:12,4001,200   
Operating expenses(25,304)(20,989)(21,309)(17,256)(5,132)
Operating loss:(12,904)(19,789)(21,309)(17,256)(5,132)
Nonoperating income47   2
Investment income, nonoperating    2
Other nonoperating income47    
Interest and debt expense76(17)   
Net loss:(12,781)(19,806)(21,309)(17,256)(5,130)
Other undisclosed net income attributable to parent3361523 
Net loss available to common stockholders, diluted:(12,778)(19,770)(21,157)(17,253)(5,130)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(12,781)(19,806)(21,309)(17,256)(5,130)
Comprehensive loss, net of tax, attributable to parent:(12,781)(19,806)(21,309)(17,256)(5,130)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: